Currently holds positions in Catalyst Pharmaceuticals Inc and Ampio Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Independent Director | Catalyst Pharmaceuticals Inc | Oct. 1, 2002 - |
Independent Director | Ampio Pharmaceuticals Inc | April 12, 2010 - |
Independent Director | Wellsky Corp | May 1, 2008 - Nov. 9, 2012 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-11-23 | 2022-11-23 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
9,999
-6.3%
17.45174,483 USD |
9,999 -6.3% | 17.45 | 174,483 USD | |
2022-11-23 | 2022-11-22 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
20,001
-11.1%
17.30346,097 USD |
20,001 -11.1% | 17.30 | 346,097 USD | |
2022-11-23 | 2022-11-21 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
70,000
-28.1%
15.231,066,170 USD |
70,000 -28.1% | 15.23 | 1,066,170 USD | |
2022-09-15 | 2022-09-14 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
20,000
-7.4%
15.75315,000 USD |
20,000 -7.4% | 15.75 | 315,000 USD | |
2022-09-15 | 2022-09-13 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
10,000
-3.6%
15.70157,000 USD |
10,000 -3.6% | 15.70 | 157,000 USD | |
2021-05-25 | 2021-05-21 |
Ampio Pharmaceuticals Inc
(AMPE)
|
S Sale |
6,737
-3.2%
2.0013,474 USD |
6,737 -3.2% | 2.00 | 13,474 USD | |
2021-04-29 | 2021-04-29 |
Ampio Pharmaceuticals Inc
(AMPE)
|
S Sale |
3,263
-1.6%
2.006,526 USD |
3,263 -1.6% | 2.00 | 6,526 USD | |
2021-04-29 | 2021-04-27 |
Ampio Pharmaceuticals Inc
(AMPE)
|
S Sale |
20,000
-8.9%
2.0040,000 USD |
20,000 -8.9% | 2.00 | 40,000 USD | |
2017-09-28 | 2017-09-27 |
Ampio Pharmaceuticals Inc
(AMPE)
|
B Purchase |
10,000
+10.6%
0.636,270 USD |
10,000 +10.6% | 0.63 | 6,270 USD | |
2017-09-22 | 2017-09-22 |
Ampio Pharmaceuticals Inc
(AMPE)
|
B Purchase |
3,000
+3.3%
0.601,800 USD |
3,000 +3.3% | 0.60 | 1,800 USD | |
2017-09-22 | 2017-09-20 |
Ampio Pharmaceuticals Inc
(AMPE)
|
B Purchase |
1,000
+1.1%
0.59592 USD |
1,000 +1.1% | 0.59 | 592 USD | |
2017-09-21 | 2017-09-19 |
Ampio Pharmaceuticals Inc
(AMPE)
|
B Purchase |
15,000
+19.8%
0.578,519 USD |
15,000 +19.8% | 0.57 | 8,519 USD | |
2013-11-20 | 2013-11-18 |
Ampio Pharmaceuticals Inc
(AMPE)
|
S Sale |
13,287
-47.3%
8.25109,666 USD |
13,287 -47.3% | 8.25 | 109,666 USD | |
2013-11-20 | 2013-11-15 |
Ampio Pharmaceuticals Inc
(AMPE)
|
S Sale |
11,320
-28.7%
8.2293,070 USD |
11,320 -28.7% | 8.22 | 93,070 USD | |
2011-11-22 | 2011-11-22 |
Ampio Pharmaceuticals Inc
(AMPE)
|
S Sale |
4,446
-11.4%
7.9835,479 USD |
4,446 -11.4% | 7.98 | 35,479 USD | |
2006-05-15 | 2006-05-12 |
Thermogenesis Holdings Inc
(THMO)
|
B Purchase |
13,000
+17.7%
4.0252,260 USD |
13,000 +17.7% | 4.02 | 52,260 USD | |
2006-05-15 | 2006-05-12 |
Thermogenesis Holdings Inc
(THMO)
|
B Purchase |
6,000
+8.9%
4.0024,000 USD |
6,000 +8.9% | 4.00 | 24,000 USD | |
2006-05-15 | 2006-05-12 |
Thermogenesis Holdings Inc
(THMO)
|
B Purchase |
2,400
+3.7%
3.999,576 USD |
2,400 +3.7% | 3.99 | 9,576 USD | |
2006-05-15 | 2006-05-12 |
Thermogenesis Holdings Inc
(THMO)
|
B Purchase |
3,600
+5.9%
3.9814,328 USD |
3,600 +5.9% | 3.98 | 14,328 USD | |
2004-12-01 | 2004-11-30 |
Thermogenesis Holdings Inc
(THMO)
|
S Sale |
67,425
-59.6%
6.20418,332 USD |
67,425 -59.6% | 6.20 | 418,332 USD |